Prescribing, Policies and Pathways
or
Medicine / Guideline | Indication | RAG rating | Document type | Place |
---|---|---|---|---|
Abatacept | Psoriatic arthritis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Abatacept | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Acromioclavicular Joint (ACJ) | n/a | Clinical pathways | South and West Hertfordshire | |
Adalimumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Adalimumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Adalimumab | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Adalimumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Allopurinol | Gout 1st line | Green | n/a | Hertfordshire and West Essex ICB |
Apremilast | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Arthroscopic Sub-acromial Decompression | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Axial Spondyloarthritis | Axial Spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Back Pain | n/a | Clinical pathways | East and North Hertfordshire | |
Baricitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Bimekizumab | Axial Spondyloarthritis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Bimekizumab | Psoriatic arthritis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Biologic and Biosimilar Medicines | Where indicated | n/a | Patient information | Hertfordshire and West Essex ICB |
Bunions | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Carpal Tunnel Syndrome | n/a | Clinical pathways | South and West Hertfordshire | |
Carpometacarpal Joint Osteoarthritis | n/a | Clinical pathways | South and West Hertfordshire | |
Certolizumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Certolizumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Certolizumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Cervical Spine and Pain | n/a | n/a | South and West Hertfordshire | |
Co-proxamol | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Co-proxamol | Pain | n/a | Patient information | Hertfordshire and West Essex ICB |
Colchicine | Gout 2nd line | Green | n/a | Hertfordshire and West Essex ICB |
De Quervains Pathway | n/a | Clinical pathways | South and West Hertfordshire | |
Dependence forming medicine | Pain - ECF FAQs | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Diastasis Recti Repair | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Dibotermin alfa | Promotion of ectopic bone formation | Red | Decision document | Hertfordshire and West Essex ICB |
Dupuytren's Contracture - Assessment | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Elbow Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Etanercept | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Etanercept | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Etanercept | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Etanercept | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Febuxostat | Gout 2nd line | Green | n/a | Hertfordshire and West Essex ICB |
Fentanyl immediate release (IR) | Pain (except for palliative care) | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Filgotinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Filgotinib | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Foot & Ankle Pain and Disorders excluding Bunions | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Foot Symptoms | Adults Only | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Functional Electrical Stimulation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Ganglion | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Glenohumeral Joint (Shoulder Pain) | n/a | Clinical pathways | South and West Hertfordshire | |
Glucosamine and chondroitin | Osteoarthritis | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Glucosamine and Chondroitin Patient Information Leaflet | Osteoarthritis | n/a | Patient information | Hertfordshire and West Essex ICB |
Golimumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Golimumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Golimumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Guselkumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Hallux Valgus (Bunion) Surgery | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Hallux Valgus (Bunion) Surgery Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Hand and Wrist including Dupuytren's, Trigger Finger and Carpal Tunnel | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Hip Arthroscopy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Hip Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Hip Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Hip Replacement Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Hyaluronan, intra-articular injection | Osteoarthritis | Double Red | NICE technology appraisal | Hertfordshire and West Essex ICB |
Hydroxychloroquine | Rheumatoid arthritis, discoid and systemic lupus erythematosus, and dermatological conditions caused or aggravated by sunlight | Amber initiation | n/a | Hertfordshire and West Essex ICB |
Ibandronic acid 50mg | Prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. | Amber initiation | n/a | Hertfordshire and West Essex ICB |
Infliximab IV | Axial spondyloarthritis - ankylosing spondylitis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Infliximab IV | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Infliximab IV | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Infliximab IV | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Injections and Radiofrequency Denervation for non-specific back pain | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Injections and Radiofrequency Denervation for non-specific back pain Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Injections for nonspecific low back pain without sciatica | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
ixekizumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
ixekizumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Knee Arthroscopy – local supplement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Knee arthroscopy for patients with osteoarthritis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Knee Arthroscopy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Knee Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Knee Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Knee Replacement Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Leflunomide | Rheumatoid Arthritis, Psoriatic Arthritis | Amber protocol | Shared care protocol | Hertfordshire and West Essex ICB |
Management of MSK conditions in patients with previous cancer | n/a | Clinical pathways | South and West Hertfordshire | |
Neck Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB | |
Open MRI | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Open Mri Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Opioid | Pain - persistent self care | n/a | Prescribing guideline | Hertfordshire and West Essex ICB |
Opioid | Pain - plan agreement | n/a | Patient information | Hertfordshire and West Essex ICB |
Opioid | Pain - review letter | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB |
Opioid Aware Campaign | n/a | Primary Care prescribing resource | Hertfordshire and West Essex ICB | |
Opioid Deprescribing | Pain - long-term prescribing for non-cancer, chronic pain in adults | n/a | Position statement | Hertfordshire and West Essex ICB |
Oxycodone and naloxone | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Paracetamol and tramadol | Pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Penicillamine | Rheumatoid Arthiritis | Amber protocol | n/a | Hertfordshire and West Essex ICB |
Prednisolone | All indications - soluble tablet | n/a | Patient information | Hertfordshire and West Essex ICB |
Prednisolone enteric coated | All indications | Double Red | n/a | Hertfordshire and West Essex ICB |
Psoriatic Arthritis | Psoriatic Arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Residential exercise therapy/rehabilitation courses for the management of Ankylosing Spondylitis | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Revision Surgery for Hip & Knee Replacements | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Rheumatoid Arthritis - moderate | Rheumatoid Arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Rheumatoid Arthritis - severe | Rheumatoid Arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Rituximab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Rotator Cuff Injury or Inflammation | n/a | Clinical pathways | South and West Hertfordshire | |
Rubefacients, benzydamine, mucopolysaccharide and cooling products (excluding topical NSAIDs and capsaicin) | Musculoskeletal pain | Double Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Sarilumab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Secukinumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Secukinumab | Axial spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Shoulder Arthroscopy | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Shoulder Arthroscopy Prior Approval Form | n/a | Prior approval form | Hertfordshire and West Essex ICB | |
Shoulder Instability Pathway | n/a | n/a | South and West Hertfordshire | |
Shoulder Pain | n/a | Clinical pathways | Hertfordshire and West Essex ICB, South and West Hertfordshire | |
Simultaneous Joint Replacement | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Spinal and Low Back Pain |SWH | n/a | Clinical pathways | South and West Hertfordshire | |
Spinal Cord Stimulation | n/a | Clinical policy | Hertfordshire and West Essex ICB | |
Tennis and Golfers Elbow | n/a | Clinical pathways | South and West Hertfordshire | |
Tocilizmuab | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Tofacitinib | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Tofacitinib | Axial Spondyloarthritis - ankylosing spondylitis | Red | Prescribing guideline | Hertfordshire and West Essex ICB |
Tofacitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Trigger Finger/Thumb | n/a | Clinical pathways | South and West Hertfordshire | |
Upadacitinib | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Upadacitinib | Rheumatoid arthritis - severe | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Upadacitinib | Rheumatoid arthritis - moderate | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Upadacitinib | Axial Spondyloarthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |
Ustekinumab | Psoriatic arthritis | Red | Prescribing pathway | Hertfordshire and West Essex ICB |